Pfizer has reached settlements with a trio of drug manufacturers that’ll extend the patent protection for one of its best-selling medicines.
In a short statement this week, Pfizer said it has cut deals with Dexcel Pharma, Hikma Pharmaceuticals and Cipla. All three companies are seeking to launch…